Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR.

Shastri, S; McNeill, J R; Wilson, T W; Poduri, R; Kaul, C; Gopalakrishnan, V

Shastri, S; McNeill, J R; Wilson, T W; Poduri, R; Kaul, C; Gopalakrishnan, V.

Affiliation

Shastri S; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education & Research, SAS Nagar, 160 062, India.

Am J Physiol Heart Circ Physiol ; 281(1): H342-9, 2001 Jul.

Article in En | MEDLINE | ID: mdl-11406502

Subject(s)

Angiotensin II/pharmacology; Endothelin-1/pharmacology; Hypertension/physiopathology; Leukotrienes/physiology; Rats, Inbred SHR/physiology; Vasoconstriction/drug effects; Vasoconstriction/physiology; Animals; Benzoquinones/pharmacology; Leukotriene Antagonists/pharmacology; Leukotrienes/pharmacology; Lipoxygenase Inhibitors/pharmacology; Male; Potassium Chloride/pharmacology; Propionates/pharmacology; Quinolines/pharmacology; Rats; Rats, Inbred WKY; Splanchnic Circulation/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Rats, Inbred SHR / Vasoconstriction / Angiotensin II / Leukotrienes / Endothelin-1 / Hypertension Limits: Animals Language: En Journal: Am J Physiol Heart Circ Physiol Year: 2001 Document type: Article

Search on Google

XML

PubMed Links